Some women who use a combination of estrogen and progestin to control the symptoms of menopause might find symptoms return when they stop the hormones, according to the latest findings from the Women?s Health Initiative (WHI), a major clinical trial of the risks and benefits of menopausal hormone therapy supported by the National Institutes of Health (NIH).
The Food and Drug Administration within the U.S. Department of Health and Human Services (HHS/FDA) announced the tentative approval of the fixed-dose combination drug product lamivudine and zidovudine tablets manufactured by Aurobindo Pharma Ltd. of Hyderabad, India.
Elderly people who use herbal supplements are less satisfied with conventional medical care than non-users and often do not tell their physicians they are combining supplements with prescription drugs, according to a survey conducted by researchers at Northern Illinois University.
It?s well-known that unprotected sun exposure significantly heightens risk for skin cancer, but a study published in the current issue of Dermatologic Surgery showed that a new topical cream can remove common pre-cancerous skin lesions with a reduced rate of recurrence compared with other therapies.
The U.S. Food and Drug Administration (FDA) advisory committee recently approved SCULPTRA (injectable poly-L-lactic acid) for use in correcting shape and contour deficiencies resulting from facial fat loss (lipoatrophy) in people with human immunodeficiency virus (HIV).
Acne, rosacea and sun damage are some of the most prevalent skin conditions treated by dermatologists. Fortunately, recent advances in laser therapies are providing new hope for millions of people who struggle with these conditions everyday.
The US Food and Drug Administration (FDA) approved a new use for TOPAMAX (topiramate) Tablets and TOPAMAX (topiramate capsules) Sprinkle Capsules as initial monotherapy in patients 10 years of age and older with partial-onset or primary generalized tonic-clonic seizures.
Under the Food and Drug Administration’s (FDA) “Consumer Health for Better Nutrition Initiative,” the Agency is announcing the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer. Based on a systematic evaluation of the available scientific data, the FDA intends to consider exercising its enforcement discretion for the following qualified health claims for breast and prostate cancer:
In a letter sent to the Food and Drug Administration, the American Academy of Dermatology Association (AADA) called on the FDA to halt Internet sales of isotretinoin, commonly known as Accutane. To assist government efforts, the AADA is providing the FDA with a preliminary list of Internet sites from which isotretinoin can be purchased.
High blood pressure, the “silent killer,” too often gets overlooked by people who have conditions that cause them pain or severe distress, a new study finds.